Qsv Equity Investors LLC Catalyst Pharmaceuticals, Inc. Put Options Transaction History
Qsv Equity Investors LLC
- $95.8 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
299Shares Held
97.6MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$411 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$200 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$132 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$65.9 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.26B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...